SensoDetect Aktiebolag Valuation
Is SDET undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Sales gegen Gleichaltrige
Price-To-Sales gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of SDET when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: SDET (SEK0.12) wird unter unserer Schätzung des Fair Value (SEK0.14) gehandelt.
Deutlich unter dem Marktwert: SDET unter dem beizulegenden Zeitwert gehandelt wird, jedoch nicht um einen signifikanten Betrag.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SDET?
Other financial metrics that can be useful for relative valuation.
What is SDET's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | kr35.71m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 15.8x |
Enterprise Value/EBITDA | -6.6x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does SDET's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 7.9x | ||
CMOTEC B Scandinavian ChemoTech | 14.8x | 55.6% | kr41.8m |
FLUI Fluicell | 12.6x | n/a | kr42.0m |
ZENI Zenicor Medical Systems | 0.8x | n/a | kr26.9m |
MEDF Medfield Diagnostics | 3.3x | n/a | kr23.6m |
SDET SensoDetect Aktiebolag | 15.8x | n/a | kr35.7m |
Price-To-Sales gegen Gleichaltrige: SDET ist auf der Grundlage des Price-To-Sales Verhältnisses (17.2x) im Vergleich zum Durchschnitt der Vergleichsgruppe (8.4x) teuer.
Price to Earnings Ratio vs Industry
How does SDET's PE Ratio compare vs other companies in the SE Medical Equipment Industry?
Price-To-Sales gegen Industrie: SDET ist teuer, wenn man sein Price-To-Sales Verhältnis (5.4x) mit dem Swedish Medical Equipment Branchendurchschnitt (4.5x) vergleicht.
Price to Sales Ratio vs Fair Ratio
What is SDET's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 15.8x |
Fair PS Ratio | n/a |
PM vs. Fair Ratio: Unzureichende Daten zur Berechnung der Price-To-Sales Fair Ratio von SDET für die Bewertungsanalyse.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analysten-Prognose: Unzureichende Daten für eine Preisprognose.